These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Therapeutic angiogenesis for revascularization in peripheral artery disease. Grochot-Przeczek A; Dulak J; Jozkowicz A Gene; 2013 Aug; 525(2):220-8. PubMed ID: 23566831 [TBL] [Abstract][Full Text] [Related]
30. Differential effects of vascular growth factors on arterial and venous angiogenesis. Blebea J; Vu JH; Assadnia S; McLaughlin PJ; Atnip RG; Zagon IS J Vasc Surg; 2002 Mar; 35(3):532-8. PubMed ID: 11877704 [TBL] [Abstract][Full Text] [Related]
31. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis. Bai Y; Bai L; Zhou J; Chen H; Zhang L Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157 [TBL] [Abstract][Full Text] [Related]
32. [Perspectives of gene therapy in ischemic syndromes of the lower limbs]. Melillo G; Capogrossi MC Recenti Prog Med; 2001 Mar; 92(3):180-3. PubMed ID: 11320847 [TBL] [Abstract][Full Text] [Related]
35. [Therapeutic angiogenesis awakens hope. New blood vessels for arterial occlusive disease patients? (interview by Dr. Judith Neumaier)]. Diehm C MMW Fortschr Med; 2002 Jul; 144(27-28):14. PubMed ID: 12198872 [No Abstract] [Full Text] [Related]
36. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Epstein SE; Fuchs S; Zhou YF; Baffour R; Kornowski R Cardiovasc Res; 2001 Feb; 49(3):532-42. PubMed ID: 11166266 [TBL] [Abstract][Full Text] [Related]
37. [Growth factors for therapeutic angiogenesis in cardiovascular diseases]. Vale PR; Losordo DW; Symes JF; Isner JM Rev Esp Cardiol; 2001 Oct; 54(10):1210-24. PubMed ID: 11591302 [TBL] [Abstract][Full Text] [Related]
38. Angiogenesis: an improved in vitro biological system and automated image-based workflow to aid identification and characterization of angiogenesis and angiogenic modulators. Santos AF; Zaltsman AB; Martin RC; Kuzmin A; Alexandrov Y; Roquemore EP; Jessop RA; van Erck MG; Verheijen JH Assay Drug Dev Technol; 2008 Oct; 6(5):693-710. PubMed ID: 19035850 [TBL] [Abstract][Full Text] [Related]
39. Cellular and molecular therapeutic modalities for arterial obstructive syndromes. Staudacher DL; Preis M; Lewis BS; Grossman PM; Flugelman MY Pharmacol Ther; 2006 Jan; 109(1-2):263-73. PubMed ID: 16243400 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]